Submitted on April 3, 2008
From the Nephrology (R.C.S., A.G., L.R.), Radiology (M.H.), and Vascular Physiology (A.E.D., J.D.) Units, Great Ormond Street Hospital and University College London Institute of Child Health; BHF Centre, Cardiovascular Division, King's College London (R.C.S., C.M.S.), London; Department of Medicine, Addenbrooke's Hospital (R.M., N.F.); Multi-Imaging Centre, Department of Anatomy (J.N.S.), Cambridge, United Kingdom; and CARIM and VitaK (L.S.), University of Maastricht, Maastricht, The Netherlands. * To whom correspondence should be addressed. E-mail: cathy.shanahan{at}kcl.ac.uk.
Background—Vascular calcification is associated with increased morbidity and mortality in stage V chronic kidney disease, yet its early pathogenesis and initiating mechanisms in vivo remain poorly understood. To address this, we quantified the calcium (Ca) load in arteries from children (10 predialysis, 24 dialysis) and correlated it with clinical, biochemical, and vascular measures. Methods and Results—Vessel Ca load was significantly elevated in both predialysis and dialysis and was correlated with the patients' mean serum Caxphosphate product. However, only dialysis patients showed increased carotid intima-media thickness and increased aortic stiffness, and calcification on computed tomography was present in only the 2 patients with the highest Ca loads. Importantly, predialysis vessels appeared histologically intact, whereas dialysis vessels exhibited evidence of extensive vascular smooth muscle cell (VSMC) loss owing to apoptosis. Dialysis vessels also showed increased alkaline phosphatase activity and Runx2 and osterix expression, indicative of VSMC osteogenic transformation. Deposition of the vesicle membrane marker annexin VI and vesicle component mineralization inhibitors fetuin-A and matrix Gla-protein increased in dialysis vessels and preceded von Kossa positive overt calcification. Electron microscopy showed hydroxyapatite nanocrystals within vesicles released from damaged/dead VSMCs, indicative of their role in initiating calcification. Conclusions—Taken together, this study shows that Ca accumulation begins predialysis, but it is the induction of VSMC apoptosis in dialysis that is the key event in disabling VSMC defense mechanisms and leading to overt calcification, eventually with clinically detectable vascular damage. Thus the identification of factors that lead to VSMC death in dialysis will be of prime importance in preventing vascular calcification.
Accepted on August 14, 2008
Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis
Rukshana C. Shroff MRCPCH,
Related Article:
Circulation 2008 118: 1689-1690.
This article has been cited by other articles:
![]() |
C. T. Chan, F. Lovren, Y. Pan, and S. Verma Nocturnal haemodialysis is associated with improved vascular smooth muscle cell biology Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3867 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W.Y. Chung, H.H. C. Yang, J. M. Kim, M. K. Sigrist, E. Chum, W. A. Gourlay, and A. Levin Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease Circulation, September 1, 2009; 120(9): 792 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koleganova, G. Piecha, E. Ritz, P. Schirmacher, A. Muller, H.-P. Meyer, and M.-L. Gross Arterial calcification in patients with chronic kidney disease Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2488 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Helas, C. Goettsch, M. Schoppet, U. Zeitz, U. Hempel, H. Morawietz, P. J. Kostenuik, R. G. Erben, and L. C. Hofbauer Inhibition of Receptor Activator of NF-{kappa}B Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice Am. J. Pathol., August 1, 2009; 175(2): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |